Seongsu Park
Founder & CEO
D&C Biotechnology Inc
The startup develops a urine chemistry analysis system that eliminates contamination and infection risks associated with traditional urine testing methods. This technology enhances the convenience and safety of diagnostic procedures for medical personnel, streamlining the testing process in clinical settings.
- Digital Health
- Healthcare Technology
- Medical Devices
Updated 6 months ago
Funding
Raised to date
$770KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a urine chemistry analysis system that eliminates contamination and infection risks associated with traditional urine testing methods. This technology enhances the convenience and safety of diagnostic procedures for medical personnel, streamlining the testing process in clinical settings.